药品可及性保障的法律问题研究
发布时间：2019-01-15 07:10
【摘要】：公共卫生需要创新，也需要每个需要医治的病人都能获取高质量的医疗产品，药品可及性的程度直接关系到人类的健康，保障药品可及性是政府义不容辞的责任。目前，我国药品可及性问题是影响我国和谐社会构建的突出问题。 本篇论文由五个部分构成，第一部分着重阐述了本次研究的背景和本次研究的意义，同时综述了国内外权威学者在该领域的研究现状及成果。第二部分为药品可及性保障概述，主要介绍药品可及性的含义，并以此为研究对象，介绍了与药品可及性保障相关的三大法律制度—药品管理法律制度、医疗保障法律制度和药品专利制度；另对药品可及性保障的法律制度的理论基础进行了介绍。第三部分对国外典型国家药品可及性保障的法律问题进行介绍，分别对美国、日本、印度三个国家的药品可及性法律问题作为对比，提出各自的优势和不足，并提出发达国家和发展中国家药品可及性保障的法律制度对我国的借鉴与启示。第四部分为中国的药品可及性保障的法律的现状及问题，从药品管管理、医疗保障及药品专利三个方面分别对我国药品可及性保障法律的现状和存在的问题作详细论述。第五部分为完善我国药品可及性法律制度的对策，在前述的基础上针对三大制度提出相应对策。 随着我国医药市场的发展，我国的公共健康面临着不太乐观的形势，我国有关的药品部门必须要采取强力措施来应对，从而较为深层次的提高我国的医药创新能力，尽可能的使药品价格降低到适合我国经济发展的水平，，从比较根本层次解决买药困难这一重大民生问题；相关立法部门加强立法，维护医药企业的正当权益，采取一定的严厉措施，进一步促进本国医药产业朝着协调的方向发展。
[Abstract]:Public health needs innovation, and every patient in need of medical treatment can obtain high quality medical products. The degree of drug accessibility is directly related to human health, and it is the government's duty to ensure drug accessibility. At present, the problem of drug accessibility is a prominent problem affecting the construction of a harmonious society in China. This paper is composed of five parts. The first part focuses on the background and significance of this study, and summarizes the research status and achievements of domestic and foreign authoritative scholars in this field. The second part is an overview of drug accessibility, mainly introduces the meaning of drug accessibility, and as a research object, introduces three major legal systems related to drug accessibility-drug management legal system. The legal system of medical security and the patent system of drugs; In addition, the theoretical basis of the legal system of drug accessibility is introduced. The third part introduces the legal problems of drug accessibility in typical foreign countries, and compares the legal problems of drug accessibility between the United States, Japan and India, and puts forward their respective advantages and disadvantages. It also puts forward the reference and enlightenment of the legal system of drug accessibility protection in developed and developing countries. The fourth part is the current situation and problems of the law of drug accessibility protection in China. From the aspects of drug management, medical security and drug patent, the current situation and existing problems of the law of drug accessibility in China are discussed in detail. The fifth part is to improve the legal system of drug accessibility in China, on the basis of the above put forward the corresponding countermeasures for the three systems. With the development of medicine market in our country, the public health of our country is facing a situation which is not very optimistic. The relevant pharmaceutical departments in our country must take strong measures to deal with it, so as to improve the ability of innovation of medicine in our country at a deeper level. As far as possible to reduce the price of drugs to the level of economic development in China, from a more fundamental level to solve the difficulty of buying drugs this major livelihood problem; The relevant legislative departments should strengthen legislation, safeguard the legitimate rights and interests of pharmaceutical enterprises, take strict measures to further promote the development of domestic pharmaceutical industry in the direction of coordination.
【学位授予单位】：武汉工程大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：D922.16;D923.42
[Abstract]:Public health needs innovation, and every patient in need of medical treatment can obtain high quality medical products. The degree of drug accessibility is directly related to human health, and it is the government's duty to ensure drug accessibility. At present, the problem of drug accessibility is a prominent problem affecting the construction of a harmonious society in China. This paper is composed of five parts. The first part focuses on the background and significance of this study, and summarizes the research status and achievements of domestic and foreign authoritative scholars in this field. The second part is an overview of drug accessibility, mainly introduces the meaning of drug accessibility, and as a research object, introduces three major legal systems related to drug accessibility-drug management legal system. The legal system of medical security and the patent system of drugs; In addition, the theoretical basis of the legal system of drug accessibility is introduced. The third part introduces the legal problems of drug accessibility in typical foreign countries, and compares the legal problems of drug accessibility between the United States, Japan and India, and puts forward their respective advantages and disadvantages. It also puts forward the reference and enlightenment of the legal system of drug accessibility protection in developed and developing countries. The fourth part is the current situation and problems of the law of drug accessibility protection in China. From the aspects of drug management, medical security and drug patent, the current situation and existing problems of the law of drug accessibility in China are discussed in detail. The fifth part is to improve the legal system of drug accessibility in China, on the basis of the above put forward the corresponding countermeasures for the three systems. With the development of medicine market in our country, the public health of our country is facing a situation which is not very optimistic. The relevant pharmaceutical departments in our country must take strong measures to deal with it, so as to improve the ability of innovation of medicine in our country at a deeper level. As far as possible to reduce the price of drugs to the level of economic development in China, from a more fundamental level to solve the difficulty of buying drugs this major livelihood problem; The relevant legislative departments should strengthen legislation, safeguard the legitimate rights and interests of pharmaceutical enterprises, take strict measures to further promote the development of domestic pharmaceutical industry in the direction of coordination.
【学位授予单位】：武汉工程大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：D922.16;D923.42
【相似文献】
相关期刊论文 前10条
1 徐兴祥;;论影响药物可及性的因素[J];法治研究;2009年06期
2 徐兴祥;;药物可及性与知识产权保护——从甲型H1N1流感防治谈起[J];电子知识产权;2009年06期
3 杨清红;;农村医疗卫生服务的可及性研究——基于CHNS数据的实证分析[J];暨南学报(哲学社会科学版);2012年08期
4 ;[J];;年期
5 ;[J];;年期
6 ;[J];;年期
7 ;[J];;年期
8 ;[J];;年期
9 ;[J];;年期
10 ;[J];;年期
相关会议论文 前10条
1 龚时薇;许q
本文编号：2408964
本文链接：https://www.wllwen.com/falvlunwen/xingzhengfalunwen/2408964.html
